Titan Pharmaceuticals Stock Filter Stocks by Fundamentals
| TTNP Stock | USD 3.48 0.37 9.61% |
Titan Pharmaceuticals fundamentals help investors to digest information that contributes to Titan Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Titan Stock. The fundamental analysis module provides a way to measure Titan Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Titan Pharmaceuticals stock.
Titan | Shares Owned by Institutions |
Titan Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Titan Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Titan Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Titan Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Titan Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Titan Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Titan Pharmaceuticals' value.| Shares | Cape Investment Advisory, Inc. | 2024-12-31 | 1.0 | Sbi Securities Co Ltd | 2024-12-31 | 1.0 | Tower Research Capital Llc | 2024-12-31 | 0.0 | Goss Wealth Management Llc | 2024-09-30 | 0.0 | Fmr Inc | 2024-09-30 | 0.0 | Bb&t Corp. | 2024-09-30 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 2.7 K | Mcf Advisors, Llc | 2024-12-31 | 165 | Bank Of America Corp | 2024-12-31 | 17.0 | Group One Trading, Lp | 2024-12-31 | 12.0 |
Titan Fundamentals
| Return On Equity | -3.69 | ||||
| Return On Asset | -1.73 | ||||
| Current Valuation | (2.61 M) | ||||
| Shares Outstanding | 914.23 K | ||||
| Shares Owned By Insiders | 45.46 % | ||||
| Shares Owned By Institutions | 1.85 % | ||||
| Number Of Shares Shorted | 27.3 K | ||||
| Price To Earning | (3.60) X | ||||
| Price To Book | 1.44 X | ||||
| Price To Sales | 3,440 X | ||||
| Gross Profit | (4.37 M) | ||||
| EBITDA | (4.56 M) | ||||
| Net Income | (4.71 M) | ||||
| Cash And Equivalents | 6.42 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 483 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.06 X | ||||
| Book Value Per Share | 4.37 X | ||||
| Cash Flow From Operations | (3.88 M) | ||||
| Short Ratio | 1.04 X | ||||
| Earnings Per Share | (6.64) X | ||||
| Target Price | 7.0 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 3.34 M | ||||
| Total Asset | 2.92 M | ||||
| Retained Earnings | (396.54 M) | ||||
| Working Capital | 2.44 M | ||||
| Current Asset | 12.24 M | ||||
| Current Liabilities | 4.85 M | ||||
| Net Asset | 2.92 M |
About Titan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Titan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.